Matrix Metalloproteinase Cleavable Nanoparticles for Tumor Microenvironment and Tumor Cell Dual-Targeting Drug Delivery
- 9 November 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 9 (46) , 40614-40627
Abstract
Matrix metalloproteinases (MMPs), mostly abundant in the tumor extracellular matrix (ECM), tumor cells, and tumor vasculatures, are closely correlated with tumor progression and metastasis. In this case, making use of MMPs was supposed to achieve site-specific drug delivery and a satisfactory tumor treatment effect. Herein, we rationally developed a novel tumor microenvironment and tumor cell dual-targeting nanoparticle by integrating a chemotherapeutic-loaded drug-loaded carrier and a versatile polypeptide-LinTT1-PVGLIG-TAT (LPT) which is composed of a multitargeting peptide-LinTT1 and a cell-penetrating peptide-TAT. The functionalized nanoparticles exhibited a superior affinity to A549 lung-cancer cells and microenvironment including angiogenesis and tumor-associated macrophages (TAMs) in our study. In addition, cellular experiments demonstrated that the cell-penetrating ability of TAT was significantly shielded by the addition of LinTT1 to the fourth lysine of the TAT via an MMP cleavable linker PVGLIG and could be recovered under the catalysis of MMPs. This design was supposed to efficiently decrease the toxicological risk to normal tissues induced by the unselectivity of TAT. The finally treatment effect investigation showed that tumor-bearing mice treated with LPT-modified nanoparticles achieved an enhanced efficacy for inhibiting tumor growth and the longest survival time as compared to other groups. Collectively, this study provides a novel robust nanoplatform which could simultaneously target the tumor microenvironment and tumor cell drug delivery for increasing the efficacy of cancer therapy.Keywords
Funding Information
- China Postdoctoral Science Foundation (2017M610278)
- Shanghai Municipal Health and Family Planning Commission (201540027)
- Fengxian District (20141001, 20151205)
- Shanghai Municipality (2017YQ048)
This publication has 43 references indexed in Scilit:
- Stapled RGD Peptide Enables Glioma-Targeted Drug Delivery by Overcoming Multiple BarriersACS Applied Materials & Interfaces, 2017
- Perspectives on Dual Targeting Delivery Systems for Brain TumorsJournal of Neuroimmune Pharmacology, 2016
- Peptide-mediated vectorization of metal complexes: conjugation strategies and biomedical applicationsDalton Transactions, 2016
- Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptideScientific Reports, 2016
- Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalizationScientific Reports, 2013
- Application of Nanoparticles on Diagnosis and Therapy in GliomasBioMed Research International, 2013
- Hurdles in anticancer drug development from a regulatory perspectiveNature Reviews Clinical Oncology, 2012
- Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptideProceedings of the National Academy of Sciences, 2011
- Anticancer drug development: the grand challengesNature Reviews Drug Discovery, 2010
- Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculatureBiomaterials, 2010